Vaccine industry leaders are blaming Health Secretary Robert F. Kennedy Jr. for falling sales, stock declines, and stalled investment in new vaccines. Executives say increased scrutiny of vaccine safety has disrupted long-standing approval and rollout expectations.
Posts tagged as “pharmaceutical stocks”
HHS Ousts Peter Marks, Sending Vaccine Stocks Tumbling and Biopharma Lamenting Loss of ‘Ally’ at FDA
HHS Ousts Peter Marks, Sending Vaccine Stocks Tumbling and Biopharma Lamenting Loss of ‘Ally’ at FDA
The reaction to the forced resignation of Peter Marks, M.D., Ph.D., director of the FDA’s agency responsible for authorizing vaccines, by markets and the pharmaceutical…